{"transactions":[{"id":1033676,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":89388,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":89388,"derivative":{"exercise_price":19.25,"expiration_date":"2026-09-27","underlying":"Common Stock","underlying_shares":89388},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1033675,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":89388,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":19.25,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":89388},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1033674,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":125490,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":125490,"derivative":{"exercise_price":28.75,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":125490},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1033673,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125490,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":28.75,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":125490},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1068703,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":22344,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":22344,"derivative":{"exercise_price":19.25,"expiration_date":"2026-09-27","underlying":"Common Stock","underlying_shares":22344},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1068702,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22344,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":19.25,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":22344},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1068701,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":31373,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":31373,"derivative":{"exercise_price":28.75,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":31373},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1068700,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-08-12T16:51:56.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31373,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":28.75,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":31373},"source":{"system":"sec-edgar","filing":"0001213900-25-075035","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390025075035/ownership.xml","form_type":"4"}},{"id":1368411,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T22:00:27.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date"}],"balance_after":350000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001213900-24-096893","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024096893/ownership.xml","form_type":"4"}},{"id":1368410,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T22:00:22.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024096890/ownership.xml","form_type":"4"}},{"id":1368643,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T22:00:20.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096889","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000121390024096889/ownership.xml","form_type":"4"}},{"id":1368405,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T22:00:16.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096887","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024096887/ownership.xml","form_type":"4"}},{"id":1368976,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:31.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096895","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390024096895/ownership.xml","form_type":"4"}},{"id":1369288,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:29.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":125000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-24-096894","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390024096894/ownership.xml","form_type":"4"}},{"id":1368770,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:25.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":600000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001213900-24-096892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024096892/ownership.xml","form_type":"4"}},{"id":1369135,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:23.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-24-096891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390024096891/ownership.xml","form_type":"4"}},{"id":1368599,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-12T17:00:18.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":75000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-24-096888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024096888/ownership.xml","form_type":"4"}},{"id":1368598,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:18.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":350000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001213900-24-096888","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024096888/ownership.xml","form_type":"4"}},{"id":1398394,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":558597,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":558597,"derivative":{"exercise_price":0.77,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":558597},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398393,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-09-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":558597,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":0.77,"expiration_date":"2024-09-27","underlying":"Common Stock","underlying_shares":558597},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398392,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":784314,"derivative":{"exercise_price":1.15,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398391,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:27:04.000Z","date":"2024-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":784314,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2024-08-14","underlying":"Common Stock","underlying_shares":784314},"source":{"system":"sec-edgar","filing":"0001213900-24-082813","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024082813/ownership.xml","form_type":"4"}},{"id":1398430,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":2234700,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":2234700,"derivative":{"exercise_price":0.77,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":2234700},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1398429,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-09-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2234700,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":0.77,"expiration_date":"2024-09-27","underlying":"Common Stock","underlying_shares":2234700},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1398428,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":3137255,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":3137255,"derivative":{"exercise_price":1.15,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":3137255},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1398427,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3137255,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2024-08-14","underlying":"Common Stock","underlying_shares":3137255},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1418833,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-08-30T20:01:05.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":false,"shares":2415,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.015,"exercise_date":"2017-04-14","expiration_date":"2024-04-14","underlying":"Common Stock","underlying_shares":2415},"source":{"system":"sec-edgar","filing":"0001213900-24-074506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024074506/ownership.xml","form_type":"4"}},{"id":1418832,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T20:01:05.000Z","date":"2024-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":48,"price":0.75,"value":36.0,"ownership":{"direct":true},"balance_after":2367,"source":{"system":"sec-edgar","filing":"0001213900-24-074506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024074506/ownership.xml","form_type":"4"}},{"id":1418831,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T20:01:05.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":true,"shares":2415,"price":0.015,"value":36.225,"ownership":{"direct":true},"balance_after":2415,"source":{"system":"sec-edgar","filing":"0001213900-24-074506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390024074506/ownership.xml","form_type":"4"}},{"id":1419003,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-08-30T16:01:03.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":false,"shares":12071,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.015,"exercise_date":"2017-03-17","expiration_date":"2024-03-17","underlying":"Common Stock","underlying_shares":12071},"source":{"system":"sec-edgar","filing":"0001213900-24-074505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390024074505/ownership.xml","form_type":"4"}},{"id":1419002,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:01:03.000Z","date":"2024-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":236,"price":0.766,"value":180.776,"ownership":{"direct":true},"balance_after":11835,"source":{"system":"sec-edgar","filing":"0001213900-24-074505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390024074505/ownership.xml","form_type":"4"}},{"id":1419001,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-30T16:01:03.000Z","date":"2024-03-04","kind":"exercise","planned":false,"acquired":true,"shares":12071,"price":0.015,"value":181.065,"ownership":{"direct":true},"balance_after":12071,"source":{"system":"sec-edgar","filing":"0001213900-24-074505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390024074505/ownership.xml","form_type":"4"}},{"id":1546618,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:21.000Z","date":"2024-04-03","kind":"grant","planned":false,"acquired":true,"shares":1165048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":1165048,"derivative":{"exercise_price":1.42,"expiration_date":"2025-04-05","underlying":"Common Stock","underlying_shares":1165048},"source":{"system":"sec-edgar","filing":"0001213900-24-030811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024030811/ownership.xml","form_type":"4"}},{"id":1546617,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:21.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1165048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2024-04-05","underlying":"Common Stock","underlying_shares":1165048},"source":{"system":"sec-edgar","filing":"0001213900-24-030811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024030811/ownership.xml","form_type":"4"}},{"id":1546544,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:20.000Z","date":"2024-04-03","kind":"grant","planned":false,"acquired":true,"shares":129450,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":129450,"derivative":{"exercise_price":1.42,"expiration_date":"2025-04-05","underlying":"Common Stock","underlying_shares":129450},"source":{"system":"sec-edgar","filing":"0001213900-24-030812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024030812/ownership.xml","form_type":"4"}},{"id":1546543,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:20.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":129450,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2024-04-05","underlying":"Common Stock","underlying_shares":129450},"source":{"system":"sec-edgar","filing":"0001213900-24-030812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390024030812/ownership.xml","form_type":"4"}},{"id":1572794,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70997,"kind":"person","name":"Smith Robert Joseph","position":1,"cik":"0002008764","reported_name":"Smith Robert Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-03-18T16:06:03.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.69,"expiration_date":"2034-03-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-24-023487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2008764/000121390024023487/ownership.xml","form_type":"4"}},{"id":1761011,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T20:15:27.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001013762-23-003532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000101376223003532/ownership.xml","form_type":"4"}},{"id":1761062,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T20:15:26.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001013762-23-003529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000101376223003529/ownership.xml","form_type":"4"}},{"id":1761010,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T20:15:24.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001013762-23-003531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000101376223003531/ownership.xml","form_type":"4"}},{"id":1761009,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2023-10-12T20:15:24.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001013762-23-003530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000101376223003530/ownership.xml","form_type":"4"}},{"id":1761179,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T16:15:37.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001013762-23-003535","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000101376223003535/ownership.xml","form_type":"4"}},{"id":1761202,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2023-10-12T16:15:35.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001013762-23-003534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000101376223003534/ownership.xml","form_type":"4"}},{"id":1761047,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2023-10-12T16:15:31.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001013762-23-003533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000101376223003533/ownership.xml","form_type":"4"}},{"id":1761110,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-10-12T16:15:21.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":550000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001013762-23-003528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000101376223003528/ownership.xml","form_type":"4"}},{"id":2024585,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":53807,"kind":"person","name":"MCGRATH DENNIS M","position":1,"cik":"0001269340","reported_name":"MCGRATH DENNIS M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2023-02-09T21:06:16.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on February 7, 2023. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.42,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-23-009756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269340/000121390023009756/ownership.xml","form_type":"4"}},{"id":2141074,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T20:09:41.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-22-062484","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390022062484/ownership.xml","form_type":"4"}},{"id":2141075,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2022-10-06T20:07:49.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-22-062480","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390022062480/ownership.xml","form_type":"4"}},{"id":2141073,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T20:06:56.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-22-062476","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390022062476/ownership.xml","form_type":"4"}},{"id":2141320,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T16:10:20.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-22-062485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390022062485/ownership.xml","form_type":"4"}},{"id":2141115,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T16:08:55.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001213900-22-062483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390022062483/ownership.xml","form_type":"4"}},{"id":2141247,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Option to Purchase Common Stock","published_at":"2022-10-06T16:08:28.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":550000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001213900-22-062481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390022062481/ownership.xml","form_type":"4"}},{"id":2141141,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T16:07:22.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-22-062478","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390022062478/ownership.xml","form_type":"4"}},{"id":2141319,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2022-10-06T16:06:16.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-22-062475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390022062475/ownership.xml","form_type":"4"}},{"id":2141376,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2022-10-06T16:05:26.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-22-062472","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390022062472/ownership.xml","form_type":"4"}},{"id":2543200,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2021-10-13T21:25:32.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-052676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021052676/ownership.xml","form_type":"4"}},{"id":2543199,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T21:25:21.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-21-052673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021052673/ownership.xml","form_type":"4"}},{"id":2543198,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T21:25:17.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-21-052675","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021052675/ownership.xml","form_type":"4"}},{"id":2543254,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:47.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":15000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-052678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021052678/ownership.xml","form_type":"4"}},{"id":2543253,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:47.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":650000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001213900-21-052678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021052678/ownership.xml","form_type":"4"}},{"id":2543355,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Option to Purchase Common Stock","published_at":"2021-10-13T17:25:45.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":650000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001213900-21-052677","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390021052677/ownership.xml","form_type":"4"}},{"id":2543410,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:40.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-21-052674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390021052674/ownership.xml","form_type":"4"}},{"id":2543257,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:27.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-21-052672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390021052672/ownership.xml","form_type":"4"}},{"id":2543570,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2021-10-13T17:25:13.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-052671","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390021052671/ownership.xml","form_type":"4"}},{"id":2543412,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-10-13T17:25:10.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-21-052670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390021052670/ownership.xml","form_type":"4"}},{"id":2624721,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T21:03:24.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 22, 2022."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-038697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021038697/ownership.xml","form_type":"4"}},{"id":2624720,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2021-07-26T21:01:55.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-21-038694","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021038694/ownership.xml","form_type":"4"}},{"id":2624719,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T21:01:03.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on July 22, 2022."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-038692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021038692/ownership.xml","form_type":"4"}},{"id":2624923,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:03:54.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on July 22, 2022."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-038698","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390021038698/ownership.xml","form_type":"4"}},{"id":2624781,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:02:58.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares."}],"balance_after":10000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-21-038696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021038696/ownership.xml","form_type":"4"}},{"id":2624780,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:02:58.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-038696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390021038696/ownership.xml","form_type":"4"}},{"id":2624828,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:02:17.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-038695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390021038695/ownership.xml","form_type":"4"}},{"id":2624784,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:01:25.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 22, 2022."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-038693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390021038693/ownership.xml","form_type":"4"}},{"id":2624922,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:00:43.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on July 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on July 22, 2022."}],"balance_after":15000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-21-038690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390021038690/ownership.xml","form_type":"4"}},{"id":2849083,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-02-18T21:09:08.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on February 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on February 16, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-010320","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021010320/ownership.xml","form_type":"4"}},{"id":2849082,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-02-18T21:07:37.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on February 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on February 16, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-010318","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390021010318/ownership.xml","form_type":"4"}},{"id":2850296,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-02-18T16:09:24.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on February 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on February 16, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-010321","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390021010321/ownership.xml","form_type":"4"}},{"id":2849371,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-02-18T16:08:26.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on February 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on February 16, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-010319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390021010319/ownership.xml","form_type":"4"}},{"id":2850291,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2021-02-18T16:06:54.000Z","date":"2021-02-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on February 16, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on February 16, 2022."}],"balance_after":25000,"derivative":{"exercise_price":1.69,"expiration_date":"2031-02-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-21-010316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390021010316/ownership.xml","form_type":"4"}},{"id":3009250,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T20:08:18.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 6, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 6, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-030795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020030795/ownership.xml","form_type":"4"}},{"id":3009249,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2020-10-09T20:07:12.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date"}],"balance_after":125000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001213900-20-030792","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020030792/ownership.xml","form_type":"4"}},{"id":3009248,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T20:06:35.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on October 6, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on October 6, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-030790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020030790/ownership.xml","form_type":"4"}},{"id":3009390,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:09:24.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 6, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 6, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-030797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390020030797/ownership.xml","form_type":"4"}},{"id":3009299,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70985,"kind":"person","name":"HOLUBIAK MYRON Z","position":1,"cik":"0001199080","reported_name":"HOLUBIAK MYRON Z","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:08:18.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-20-030794","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1199080/000121390020030794/ownership.xml","form_type":"4"}},{"id":3009338,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:07:13.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-20-030793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390020030793/ownership.xml","form_type":"4"}},{"id":3009306,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:06:35.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 6, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 6, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-030791","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390020030791/ownership.xml","form_type":"4"}},{"id":3009389,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:05:28.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on October 6, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on October 6, 2021."}],"balance_after":35000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001213900-20-030788","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390020030788/ownership.xml","form_type":"4"}},{"id":3082853,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70984,"kind":"person","name":"Czuczman Myron","position":1,"cik":"0001817716","reported_name":"Czuczman Myron","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Purchase Common Stock) )","published_at":"2020-07-15T16:35:02.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares of the Company's common stock underlying the grant vest on the one-year anniversary of the Vesting Commencement Date, July 14, 2020, with the remainder vesting in 24 equal monthly installments thereafter, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.19,"expiration_date":"2030-07-14","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001213900-20-017558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817716/000121390020017558/ownership.xml","form_type":"4"}},{"id":3085477,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-07-09T20:08:14.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 7, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 7, 2021."}],"balance_after":25000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-017086","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020017086/ownership.xml","form_type":"4"}},{"id":3085478,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-07-09T20:06:18.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 7, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 7, 2021."}],"balance_after":25000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-017080","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390020017080/ownership.xml","form_type":"4"}},{"id":3085638,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-07-09T16:09:17.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on July 7, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on July 7, 2021."}],"balance_after":25000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-017089","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390020017089/ownership.xml","form_type":"4"}},{"id":3085639,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-07-09T16:07:09.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 7, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 7, 2021."}],"balance_after":25000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-017083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390020017083/ownership.xml","form_type":"4"}},{"id":3085516,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2020-07-09T16:05:21.000Z","date":"2020-07-07","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on July 7, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on July 7, 2021."}],"balance_after":25000,"derivative":{"exercise_price":1.39,"expiration_date":"2030-07-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-20-017075","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390020017075/ownership.xml","form_type":"4"}},{"id":3394723,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70980,"kind":"person","name":"Holuka Eugene Myron","position":1,"cik":"0001678292","reported_name":"Holuka Eugene Myron","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T20:10:20.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 8, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-020117","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390019020117/ownership.xml","form_type":"4"}},{"id":3394622,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70981,"kind":"person","name":"Dutia Suren G","position":1,"cik":"0001514063","reported_name":"Dutia Suren G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T20:08:02.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 8, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-020113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390019020113/ownership.xml","form_type":"4"}},{"id":3394621,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70983,"kind":"person","name":"Bartushak Jaime","position":1,"cik":"0001725077","reported_name":"Bartushak Jaime","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2019-10-10T20:06:40.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-19-020111","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1506251/000121390019020111/ownership.xml","form_type":"4"}},{"id":3394748,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70986,"kind":"person","name":"Webb Carol","position":1,"cik":"0001671111","reported_name":"Webb Carol","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T16:16:30.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options will vest in full on October 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full on October 8, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-020126","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671111/000121390019020126/ownership.xml","form_type":"4"}},{"id":3394655,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123226,"kind":"person","name":"SAFIR HOWARD","position":1,"cik":"0001221559","reported_name":"SAFIR HOWARD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T16:15:10.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 8, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-020124","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1221559/000121390019020124/ownership.xml","form_type":"4"}},{"id":3394728,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T16:14:02.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":175000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001213900-19-020122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390019020122/ownership.xml","form_type":"4"}},{"id":3394749,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":123229,"kind":"person","name":"Kane William","position":1,"cik":"0001671585","reported_name":"Kane William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T16:11:22.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options vest in full on October 8, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in full on October 8, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-19-020119","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671585/000121390019020119/ownership.xml","form_type":"4"}}],"next_cursor":"2019-10-10T16:11:22.000000Z,3394749"}